litlas
Log inCreate account

Yuquan Wei

Active 1994–2025

265
Papers
35,488
Citations
106
h-index
250
i10-index

Citations

Citations per year for Yuquan Wei1988: 1 citations1989: 1 citations1992: 1 citations1995: 3 citations1996: 5 citations1997: 7 citations1998: 6 citations1999: 11 citations2000: 15 citations2001: 7 citations2002: 7 citations2003: 11 citations2004: 12 citations2005: 8 citations2006: 14 citations2007: 9 citations2008: 15 citations2009: 29 citations2010: 38 citations2011: 44 citations2012: 101 citations2013: 91 citations2014: 143 citations2015: 169 citations2016: 206 citations2017: 251 citations2018: 278 citations2019: 951 citations2020: 1,517 citations2021: 2,059 citations2022: 1,864 citations2023: 1,720 citations2024: 2,919 citations2025: 1,587 citations2026: 43 citations1990–1991: no citations, so these years are not shown1993–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 6,569 citing papers, 33.9% of this breakdownUnited States: 2,987 citing papers, 15.4% of this breakdownIndia: 852 citing papers, 4.4% of this breakdownUnited Kingdom: 576 citing papers, 3% of this breakdownGermany: 552 citing papers, 2.9% of this breakdownItaly: 514 citing papers, 2.7% of this breakdownSouth Korea: 506 citing papers, 2.6% of this breakdownIran: 471 citing papers, 2.4% of this breakdownAustralia: 407 citing papers, 2.1% of this breakdownJapan: 336 citing papers, 1.7% of this breakdownSpain: 328 citing papers, 1.7% of this breakdownCanada: 324 citing papers, 1.7% of this breakdown
0%33.9%Other 25.5%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology36.3%
  • Medicine35.8%
  • Immunology and Microbiology10.7%
  • Engineering4.3%
  • Materials Science3.1%
  • Computer Science1.8%
  • Other8%

Topics

  • RNA Interference and Gene Delivery2.4%
  • Immunotherapy and Immune Responses2.4%
  • SARS-CoV-2 and COVID-19 Research2.1%
  • Immune cells in cancer1.9%
  • Cancer Immunotherapy and Biomarkers1.7%
  • Autophagy in Disease and Therapy1.7%
  • Other87.8%

Coauthors

All papers

Open in search
  1. Targeting TGF-β signal transduction for fibrosis and cancer therapy

    Authors: Dandan Peng, Minyang Fu, Manni Wang, Yuquan Wei, Xiawei Wei - Molecular Cancer 2022 cited by 1,008

  2. Vaccine adjuvants: mechanisms and platforms

    Authors: Tingmei Zhao, Yulong Cai, Yujie Jiang, Xuemei He, Yuquan Wei, Yifan Yu, Xiaohe Tian - Signal Transduction and Targeted Therapy 2023 cited by 843

  3. Cancer vaccines as promising immuno-therapeutics: platforms and current progress

    Authors: Jian Liu, Minyang Fu, Manni Wang, Dandan Wan, Yuquan Wei, Xiawei Wei - Journal of Hematology & Oncology 2022 cited by 694

  4. Targeting PI3K in cancer: mechanisms and advances in clinical trials

    Authors: Jing Yang, Ji Nie, Xuelei Ma, Yuquan Wei, Yong Peng, Xiawei Wei - Molecular Cancer 2019 cited by 1,560

  5. cGAS-STING pathway in cancer biotherapy

    Authors: Yang Wang, Jingwen Luo, Aqu Alu, Xuejiao Han, Yuquan Wei, Xiawei Wei - Molecular Cancer 2020 cited by 387

  6. Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

    Authors: You Lü, Jianxin Xue, Tao Deng, Xiaojuan Zhou, Kun Yu, Lei Deng, Meijuan Huang, Xin Yi, Maozhi Liang, Yu Wang, Haige Shen, Ruizhan Tong, Wenbo Wang, Li Li, Jin Sook Song, Jing Li, Xiaoxing Su, Zhenyu Ding, Youling Gong, Jiang Zhu, Yongsheng Wang, Bingwen Zou, Yan Zhang, Yanying Li, Lin Zhou, Yongmei Liu, Min Yu, Yuqi Wang, Xuanwei Zhang, Limei Yin, Xuefeng Xia, Yong Zeng, Qiao Zhou, Binwu Ying, Chong Chen, Yuquan Wei, Weimin Li, Tony Mok - Nature Medicine 2020 cited by 537

  7. mRNA vaccine: a potential therapeutic strategy

    Authors: Yang Wang, Ziqi Zhang, Jingwen Luo, Xuejiao Han, Yuquan Wei, Xiawei Wei - Molecular Cancer 2021 cited by 410

  8. Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting

    Authors: Maosen Xu, Yang Wang, Ruolan Xia, Yuquan Wei, Xiawei Wei - Cell Proliferation 2021 cited by 377

  9. Targeting the tumor stroma for cancer therapy

    Authors: Maosen Xu, Tao Zhang, Ruolan Xia, Yuquan Wei, Xiawei Wei - Molecular Cancer 2022 cited by 352

  10. Role of lysosomes in physiological activities, diseases, and therapy

    Authors: Ziqi Zhang, Pengfei Yue, Tianqi Lu, Yang Wang, Yuquan Wei, Xiawei Wei - Journal of Hematology & Oncology 2021 cited by 348

  11. AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications

    Authors: Chenjing Zhu, Yuquan Wei, Xiawei Wei - Molecular Cancer 2019 cited by 503

  12. CCL5/CCR5 axis in human diseases and related treatments

    Authors: Zhen Zeng, Tianxia Lan, Yuquan Wei, Xiawei Wei - Genes & Diseases 2021 cited by 400

  13. Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer

    Authors: Zhenyu Ding, Qing Li, Rui Zhang, Li Xie, Yang Shu, Song Gao, Peipei Wang, Xiaoqing Su, Yun Qin, Yuelan Wang, Juemin Fang, Zhongzheng Zhu, Xuyang Xia, Guochao Wei, Hui Wang, Hong Qian, Xianling Guo, Zhibo Gao, Yu Wang, Yuquan Wei, Qing Xu, Heng Xu, Li Yang - Signal Transduction and Targeted Therapy 2021 cited by 263

  14. Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin

    Authors: Yuan Cheng, Fei Mo, Qingfang Li, Xuejiao Han, Houhui Shi, Siyuan Chen, Yuquan Wei, Xiawei Wei - Molecular Cancer 2021 cited by 205

  15. Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy

    Authors: Xiangrong Song, Chao Liu, Ning Wang, Hai Huang, Siyan He, Changyang Gong, Yuquan Wei - Advanced Drug Delivery Reviews 2020 cited by 207

  16. Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials

    Authors: Yanlin Song, Zhenfei Bi, Yu Liu, Furong Qin, Yuquan Wei, Xiawei Wei - Genes & Diseases 2022 cited by 202

  17. Epigenetic regulation of macrophages: from homeostasis maintenance to host defense

    Authors: Siyuan Chen, Jing Yang, Yuquan Wei, Xiawei Wei - Cellular and Molecular Immunology 2019 cited by 306

  18. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity

    Authors: H. J. Yang, Wei Wang, Zimin Chen, Shuaiyao Lu, Fanli Yang, Zhenfei Bi, Linlin Bao, Fei Mo, Xue Li, Yong Huang, Weiqi Hong, Yun Yang, Yuan Zhao, Fei Ye, Sheng Lin, Wei Deng, Hua Chen, Lei Hong, Ziqi Zhang, Min Luo, Hong Gao, Yue Zheng, Yanqiu Gong, Xiaohua Jiang, Yanfeng Xu, Qi Lv, Dan Li, Manni Wang, Fengdi Li, Shunyi Wang, Guanpeng Wang, Pin Yü, Yajin Qu, Li Yang, Hongxin Deng, Aiping Tong, Jiong Li, Zhenling Wang, Jinliang Yang, Guobo Shen, Zhiwei Zhao, Yuhua Li, Jingwen Luo, Hongqi Liu, Wenhai Yu, Mengli Yang, Jingwen Xu, Junbin Wang, Haiyan Li, Haixuan Wang, Dexuan Kuang, Panpan Lin, Zhengtao Hu, Wei Guo, Wei Cheng, Yanlin He, Xiangrong Song, Chong Chen, Zhihong Xue, Shaohua Yao, Lu Chen, Xuelei Ma, Siyuan Chen, Maling Gou, Weijin Huang, Youchun Wang, Changfa Fan, Zhixin Tian, Ming Shi, Fu‐Sheng Wang, Lunzhi Dai, Min Wu, Gen Li, Guangyu Wang, Yong Peng, Zhiyong Qian, Canhua Huang, Johnson Yiu‐Nam Lau, Zhenglin Yang, Yuquan Wei, Xiaobo Cen, Xiaozhong Peng, Chuan Qin, Kang Zhang, Guangwen Lu, Xiawei Wei - Nature 2020 cited by 849

  19. Biodegradable and injectable in situ cross-linking chitosan-hyaluronic acid based hydrogels for postoperative adhesion prevention

    Authors: Ling Li, Ning Wang, Xun Jin, Rui Deng, Shihong Nie, Lu Sun, Qinjie Wu, Yuquan Wei, Changyang Gong - Biomaterials 2014 cited by 450

  20. Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer

    Authors: Zhen Zeng, Minyang Fu, Yuan Hu, Yuquan Wei, Xiawei Wei, Min Luo - Molecular Cancer 2023 cited by 120

  21. SARS-CoV-2 M pro inhibitors with antiviral activity in a transgenic mouse model

    Authors: Jingxin Qiao, Yueshan Li, Rui Zeng, Feng‐Liang Liu, Rong‐Hua Luo, Chong Huang, Yifei Wang, Jie Zhang, Baoxue Quan, C. Shen, Xin Mao, Xinlei Liu, Weining Sun, Wei Yang, Xincheng Ni, Kai Wang, Ling Xu, Zilei Duan, Qing-Cui Zou, Hai-Lin Zhang, Wang Qu, Yanghaopeng Long, Minghua Li, Ruicheng Yang, Xiaolong Liu, Jing You, Yangli Zhou, Rui Yao, Wenpei Li, Jing-Ming Liu, Pei Chen, Yang Liu, Guifeng Lin, Xin Yang, Jun Zou, Linli Li, Yiguo Hu, Guangwen Lu, Weimin Li, Yuquan Wei, Yong‐Tang Zheng, Jian Lei, Shengyong Yang - Science 2021 cited by 450

  22. Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants

    Authors: Na Fan, Kepan Chen, Rong Zhu, Zhongwei Zhang, Hai Huang, Shugang Qin, Qian Zheng, Zhongshan He, Xi He, Wen Xiao, Yupei Zhang, Yongjun Gu, Changchun Zhao, Yongmei Liu, Xin Jiang, Shuai Cheng Li, Yuquan Wei, Xiangrong Song - Science Advances 2022 cited by 96

  23. KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming

    Authors: Feifei Na, Xiangyu Pan, Jingyao Chen, Xuelan Chen, Manli Wang, Pengliang Chi, Liting You, Lanxin Zhang, Ailing Zhong, Lei Zhao, Siqi Dai, Mengsha Zhang, Yiyun Wang, Bo Wang, Jianan Zheng, Yuying Wang, Jing Xu, Jian Wang, Baohong Wu, Mei Chen, Hongyu Liu, Jianxin Xue, Meijuan Huang, Youling Gong, Jiang Zhu, Lin Zhou, Yan Zhang, Min Yu, Panwen Tian, Mingyu Fan, Zhenghao Lu, Zhihong Xue, Yinglan Zhao, Hanshuo Yang, Chengjian Zhao, Yuan Wang, Junhong Han, Shengyong Yang, Dan Xie, Lu Chen, Qian Zhong, Mu‐Sheng Zeng, Scott W. Lowe, You Lü, Yu Liu, Yuquan Wei, Chong Chen - Nature Cancer 2022 cited by 120

  24. mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids

    Authors: Kepan Chen, Na Fan, Hai Huang, Xin Jiang, Shugang Qin, Wen Xiao, Qian Zheng, Yupei Zhang, Xing Duan, Zeyi Qin, Yongmei Liu, Jun Zeng, Yuquan Wei, Xiangrong Song - Advanced Functional Materials 2022 cited by 107